Tylvalosin information

Tylvalosin
Clinical data
Trade names	Aiviosin
AHFS/Drugs.com	Veterinary Use
License data	US DailyMed: Tylvalosin;
Routes of; administration	By mouth
Drug class	Macrolide antibiotic
ATCvet code	QJ01FA92 (WHO) ;
Legal status
Legal status	US: ℞-only;
Identifiers
CAS Number	63409-12-1; as tartrate: 63428-13-7;
PubChem CID	6441094;
DrugBank	DB11554; as tartrate: DBSALT001708;
ChemSpider	4945313; as tartrate: 30790860;
UNII	9T02S42WQO; as tartrate: AL5667FY0W;
KEGG	D10032; as tartrate: D10034;
ChEMBL	ChEMBL2103834;
CompTox Dashboard (EPA)	DTXSID901016510 ;
ECHA InfoCard	100.058.284
Chemical and physical data
Formula	C53H87NO19
Molar mass	1042.267 g·mol−1
3D model (JSmol)	Interactive image; as tartrate: Interactive image;
	SMILES CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC; ; as tartrate: O[C@H]([C@@H](O)C(O)=O)C(O)=O.CC[C@H]1OC(=O)C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(\C)=C\[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC;
	InChI InChI=1S/C53H87NO19/c1-16-38-36(26-65-52-49(64-15)48(63-14)44(60)31(7)67-52)22-28(4)17-18-37(57)29(5)23-35(19-20-55)46(30(6)39(69-34(10)56)24-41(59)70-38)73-51-45(61)43(54(12)13)47(32(8)68-51)72-42-25-53(11,62)50(33(9)66-42)71-40(58)21-27(2)3/h17-18,20,22,27,29-33,35-36,38-39,42-52,60-62H,16,19,21,23-26H2,1-15H3/b18-17+,28-22+/t29-,30+,31-,32-,33+,35+,36-,38-,39-,42+,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-/m1/s1; Key:KCJJINQANFZSAM-HZDSEHBESA-N; ; as tartrate: InChI=1S/C53H87NO19.C4H6O6/c1-16-38-36(26-65-52-49(64-15)48(63-14)44(60)31(7)67-52)22-28(4)17-18-37(57)29(5)23-35(19-20-55)46(30(6)39(69-34(10)56)24-41(59)70-38)73-51-45(61)43(54(12)13)47(32(8)68-51)72-42-25-53(11,62)50(33(9)66-42)71-40(58)21-27(2)3;5-1(3(7)8)2(6)4(9)10/h17-18,20,22,27,29-33,35-36,38-39,42-52,60-62H,16,19,21,23-26H2,1-15H3;1-2,5-6H,(H,7,8)(H,9,10)/b18-17+,28-22+;/t29-,30+,31-,32-,33+,35+,36-,38-,39-,42+,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-;1-,2-/m11/s1; Key:OLLSDNUHBJHKJS-XKORHJEPSA-N;

Tylvalosin, sold under the brand name Aiviosin, is a macrolide antibiotic used for the treatment of bacterial infections in swine.^[3] It is used as tylvalosin tartrate.^[3]

^ "Aiviosin- tylvalosin granule". DailyMed. 29 November 2021. Retrieved 13 December 2023.
^ "Aiviosin- tylvalosin tartrate granule, for solution". DailyMed. 29 November 2021. Retrieved 13 December 2023.
^ ^a ^b ^c "Freedom of Information Summary Aiviosin NADA 141-336" (PDF). Retrieved 13 December 2023. This article incorporates text from this source, which is in the public domain.

[Aiviosin_FDA_label-1] "Aiviosin- tylvalosin granule". DailyMed. 29 November 2021. Retrieved 13 December 2023.

[2] "Aiviosin- tylvalosin tartrate granule, for solution". DailyMed. 29 November 2021. Retrieved 13 December 2023.

[Aiviosin_FOI_Summary-3] "Freedom of Information Summary Aiviosin NADA 141-336" (PDF). Retrieved 13 December 2023. This article incorporates text from this source, which is in the public domain.

Tylvalosin information

and 5 Related for: Tylvalosin information

Tylvalosin

Tylosin

ATC code J01

Eravacycline

Dihydrostreptomycin